Good evening :)
Place Order
Add to Watchlist

Brooks Laboratories Ltd

BROOKS

Brooks Laboratories Ltd

BROOKS
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹224 cr, stock is ranked 2,257
High RiskStock is 4.37x as volatile as Nifty
84.780.99% (-0.85)
84.780.99% (-0.85)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹224 cr, stock is ranked 2,257
High RiskStock is 4.37x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹224 cr, stock is ranked 2,257
High RiskStock is 4.37x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-11.473.04
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
44.336.050.57%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Brooks Laboratories Ltd. is a Contract Manufacturing Company. The Company manufacturers molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 6.79%, vs industry avg of 4.63%

Constant Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 0.46%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue81.7057.6655.9557.9170.1077.9991.9863.7680.4480.45
Raw Materialssubtract52.6037.2041.5440.5750.1351.7766.2847.4597.3997.40
Power & Fuel Costsubtract2.051.543.622.562.902.703.993.23
Employee Costsubtract5.206.169.6510.0411.1612.0416.8516.00
Selling & Administrative Expensessubtract6.035.275.694.865.886.218.576.21
Operating & Other expensessubtract3.052.324.145.363.544.019.7520.04
Depreciation/Amortizationsubtract1.161.676.456.506.657.147.357.031.771.77
Interest & Other Itemssubtract0.791.012.402.963.353.103.102.180.840.84
Taxes & Other Itemssubtract0.180.82-3.72-0.1410.8610.38-12.61-17.470.030.03
EPS5.480.86-7.12-7.62-11.05-7.80-4.53-8.38-7.67-7.85
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CareLabs & Life Sciences Services

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Brooks Laboratories Ltd-11.473.04
Divi's Laboratories Ltd76.039.530.65%
Syngene International Ltd57.916.940.17%
Aarti Pharmalabs Ltd25.633.570.49%

Price Comparison

Compare BROOKS with any stock or ETF
Compare BROOKS with any stock or ETF
BROOKS
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Increased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 1.45%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding63.59%3.86%0.00%0.00%32.55%

Aug 2023

Sep 2023

Dec 2023

Mar 2024

Shareholding History

MarJunAugSepDec '23Mar0.00%0.00%1.25%2.46%3.86%3.86%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 2 Mutual Funds holding Brooks Laboratories Ltd



Funds (Top 2)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Quant Business Cycle Fund - Direct Plan Growth

Growth
2.0419%0.34%-0.11%19/54 (-3)
quant Healthcare Fund - Growth - Direct Plan

Growth
1.7720%1.39%-0.32%19/33 (-4)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

BROOKS has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time